Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial | Zendy

Katharine Dunlop | Zendy; Jack Sheen | Zendy; Laura Schulze | Zendy; Peter Fettes | Zendy; Farrokh Mansouri | Zendy; Kfir Feffer | Zendy; Daniel M. Blumberger | Zendy; Zafiris J. Daskalakis | Zendy; Sidney H. Kennedy | Zendy; Peter Giacobbe | Zendy; D. Blake Woodside | Zendy; Jonathan Downar | Zendy

Open Access

Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial

Author(s) -

Katharine Dunlop,

Jack Sheen,

Laura Schulze,

Peter Fettes,

Farrokh Mansouri,

Kfir Feffer,

Daniel M. Blumberger,

Zafiris J. Daskalakis,

Sidney H. Kennedy,

Peter Giacobbe,

D. Blake Woodside,

Jonathan Downar

Publication year - 2019

Publication title -

brain stimulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.685

H-Index - 81

eISSN - 1935-861X

pISSN - 1876-4754

DOI - 10.1016/j.brs.2019.10.020

Subject(s) - transcranial magnetic stimulation , randomized controlled trial , stimulation , depression (economics) , placebo , treatment resistant depression , deep transcranial magnetic stimulation , medicine , psychology , prefrontal cortex , supplementary motor area , refractory (planetary science) , anesthesia , antidepressant , physical medicine and rehabilitation , hippocampus , psychiatry , neuroscience , functional magnetic resonance imaging , cognition , macroeconomics , physics , alternative medicine , pathology , astrobiology , economics

Dorsomedial prefrontal cortex (DMPFC) repetitive transcranial magnetic stimulation (rTMS) is a novel intervention for treatment-refractory depression (TRD). To date, many open-label case series and one randomized controlled trial of modest sample size have provided preliminary evidence that DMPFC-rTMS is an effective treatment for TRD. Here, we report the results of a large, double-blinded, sham-controlled trial of DMPFC-rTMS for TRD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research